We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Scientists Sequence the H hepaticus Genome

By Biotechdaily staff writers
Posted on 14 Jul 2003
The complete genomic sequence of the bacterium Helicobacter hepaticus has been decoded and functionally annotated. More...
The genome sequence analysis appeared in the June 16, 2003, online issue of the Proceedings of the National Academy of Sciences USA.

The sequencing was conducted by a consortium coordinated by Sebastian Suerbaum, a professor at the University of Wurzburg (Germany), and included scientists from the Massachusetts Institute of Technology (Cambridge, USA), Genedata (Basel, Switzerland), and MWG Biotech AG (Ebersberg, Germany). In the sequencing, MWG Biotech applied its DNA microarrays for the evaluation of gene activity, while Genedata provided its Phylosopher PathoLead solution, combining a genomics approach with the analysis of data generated with the DNA microarrays.

H hepaticus, a close relative of H pylori, causes chronic hepatitis and liver cancer in mice. A comparative analysis of the genome sequences of H hepaticus and H pylori should provide valuable insights into the pathogenic mechanisms of bacteria to promote chronic infection, inflammation, and cancer, according to the scientists. The sequence is available on MWG's website (www.the.mwg.com).

"The collaboration has complemented our expertise on the pathogenic Helicobacter species with the outstanding competence of MWG in high-throughput sequencing and Genedata in the computational analysis of experimental data and thus laid the foundation of this success story,” said Prof. Suerbaum.




Related Links:
MWG Biotech

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.